Sanofi SA
SNY46.860USD
+0.240+0.51%
收盤 09/16, 16:00（美東）報價延遲15分鐘
114.07B總市值
11.34本益比TTM
關於 Sanofi SA 公司
賽諾菲 SA 是一家總部位於法國的醫療保健公司。該公司專注於患者需求，從事治療解決方案的研究、開發、製造和營銷。其三個運營部門爲：製藥、消費者保健 (CHC) 和疫苗。製藥包括：免疫學、多發性硬化症/神經病學、腫瘤學、罕見疾病、罕見血液病、心血管、糖尿病、成熟處方產品。疫苗部門包括所有地理區域的賽諾菲巴斯德商業運營以及專門針對疫苗的研究、開發和生產活動。CHC 部門包括賽諾菲消費者保健產品的商業運營以及專門針對這些產品的研究、開發和生產活動。該公司合作或特許經營開發的產品包括 Dupixent、Aubagio、Lemtrada、Cerezyme、Lumizyme、Jevtana 和 Fabrazyme。
公司簡介
公司代碼SNY
公司名稱Sanofi SA
上市日期Jul 01, 2002
CEOMr. Paul Hudson, Ph.D.
員工數量84587
證券類型Depository Receipt
年結日Jul 01
公司地址46 Avenue de la Grande Armee
城市PARIS
上市交易所NASDAQ Global Select Consolidated
國家France
郵編75017
電話33153774000
網址https://www.sanofi.com/
公司代碼SNY
上市日期Jul 01, 2002
CEOMr. Paul Hudson, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Dr. Jean-Paul Kress, M.D.
Dr. Jean-Paul Kress, M.D.
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Ms. Audrey Duval Derveloy
Ms. Audrey Duval Derveloy
Executive Vice President - Corporate Affairs, Member of the Executive Committee
Executive Vice President - Corporate Affairs, Member of the Executive Committee
--
--
Ms. Clotilde Delbos
Ms. Clotilde Delbos
Independent Director
Independent Director
--
--
Mr. Frederic Oudea
Mr. Frederic Oudea
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Dr. Jean-Paul Kress, M.D.
Dr. Jean-Paul Kress, M.D.
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
United States
4.90B
47.06%
Rest of the World (Japan, South Korea, Canada, Australia, New Zealand)
2.62B
25.20%
Europe
2.15B
20.65%
China
737.01M
7.08%
業務
地區
暫無數據
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Dodge & Cox
2.95%
Fisher Investments
0.54%
Invesco Advisers, Inc.
0.35%
Capital World Investors
0.34%
Managed Account Advisors LLC
0.31%
其他
95.51%
持股股東
持股股東
佔比
Dodge & Cox
2.95%
Fisher Investments
0.54%
Invesco Advisers, Inc.
0.35%
Capital World Investors
0.34%
Managed Account Advisors LLC
0.31%
其他
95.51%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
5.30%
Investment Advisor
3.98%
Research Firm
0.77%
Hedge Fund
0.13%
Bank and Trust
0.07%
Family Office
0.02%
Pension Fund
0.02%
其他
89.72%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1261
264.33M
10.86%
-14.23M
2025Q1
1286
268.29M
10.62%
-13.21M
2024Q4
1263
270.44M
10.70%
-30.67M
2024Q3
1239
286.03M
11.43%
-5.72M
2024Q2
1248
275.46M
11.01%
-5.50M
2024Q1
1232
261.25M
10.33%
-7.62M
2023Q4
1213
251.25M
9.93%
-18.33M
2023Q3
1178
256.18M
10.15%
-15.97M
2023Q2
1173
257.65M
10.20%
-26.92M
2023Q1
1174
268.83M
10.66%
-6.19M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
73.19M
2.9%
-2.03M
-2.70%
Mar 31, 2025
Fisher Investments
13.57M
0.54%
+1.06M
+8.43%
Mar 31, 2025
Invesco Advisers, Inc.
11.37M
0.45%
-3.25K
-0.03%
Mar 31, 2025
Capital World Investors
8.32M
0.33%
+8.32M
--
Mar 31, 2025
Managed Account Advisors LLC
7.57M
0.3%
-172.21K
-2.22%
Mar 31, 2025
Barrow Hanley Global Investors
7.35M
0.29%
-347.84K
-4.52%
Mar 31, 2025
T. Rowe Price Associates, Inc.
11.03M
0.44%
+193.02K
+1.78%
Mar 31, 2025
Wellington Management Company, LLP
4.43M
0.18%
-56.88K
-1.27%
Mar 31, 2025
Putnam Investment Management, L.L.C.
3.72M
0.15%
+573.69K
+18.23%
Mar 31, 2025
Boston Partners
4.09M
0.16%
-1.31M
-24.22%
Mar 31, 2025
查看更多
持股ETF
更新時間: 9月2日 週二
更新時間: 9月2日 週二
機構名稱
佔比
VanEck Pharmaceutical ETF
3.29%
Invesco International Dividend Achievers ETF
2.72%
Putnam Focused Large Cap Value ETF
2.24%
Brandes US Value ETF
1.98%
Altrius Global Dividend ETF
1.61%
ProShares Ultra Nasdaq Biotechnology
1.41%
American Century Focused Large Cap Value ETF
1.32%
Invesco Nasdaq Biotechnology ETF
1.26%
Invesco ESG NASDAQ Next Gen 100 ETF
0.94%
SP Funds S&P World (ex-US) ETF
0.92%
查看更多
VanEck Pharmaceutical ETF
佔比3.29%
Invesco International Dividend Achievers ETF
佔比2.72%
Putnam Focused Large Cap Value ETF
佔比2.24%
Brandes US Value ETF
佔比1.98%
Altrius Global Dividend ETF
佔比1.61%
ProShares Ultra Nasdaq Biotechnology
佔比1.41%
American Century Focused Large Cap Value ETF
佔比1.32%
Invesco Nasdaq Biotechnology ETF
佔比1.26%
Invesco ESG NASDAQ Next Gen 100 ETF
佔比0.94%
SP Funds S&P World (ex-US) ETF
佔比0.92%
分紅派息
近5年累計派現
23.51B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Mar 26, 2024
SNY.NB Final Cash Dividend of gross USD 2.036908 paid on Jun 06, 2024 going ex on May 09, 2024
May 10, 2024
Jun 06, 2024
May 09, 2024
Feb 15, 2023
SNY.NB Final Cash Dividend of gross USD 1.900085 paid on Jun 23, 2023 going ex on May 30, 2023
May 31, 2023
Jun 23, 2023
May 30, 2023
Apr 20, 2022
SNY.NB Final Cash Dividend of gross USD 1.74684 paid on May 31, 2022 going ex on May 04, 2022
May 05, 2022
May 31, 2022
May 04, 2022
Mar 24, 2021
SNY.NB Final Cash Dividend of gross USD 1.928784 paid on May 26, 2021 going ex on May 03, 2021
May 04, 2021
May 26, 2021
May 03, 2021
Mar 05, 2020
SNY.NB Final Cash Dividend of gross USD 1.699399 paid on May 26, 2020 going ex on Apr 30, 2020
May 01, 2020
May 26, 2020
Apr 30, 2020
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
